AMRX icon

Amneal Pharmaceuticals
AMRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$16
19% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Truist Securities
Truist Securities
Les Sulewski
0% 1-yr AMRX win rate
2 Mar ‘26 9 hours ago
Barclays
Barclays
Glen Santangelo
100% 1-yr AMRX win rate
9 Dec ‘25 2 months ago